• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A response to "Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study".

作者信息

Shang Xiang

机构信息

Department of Pharmacy, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, China.

出版信息

Int J Clin Pharm. 2023 Oct;45(5):1307-1308. doi: 10.1007/s11096-023-01613-w. Epub 2023 Jun 15.

DOI:10.1007/s11096-023-01613-w
PMID:37318752
Abstract
摘要

相似文献

1
A response to "Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study".对《CYP2D6药物遗传表型和表型转化对抗抑郁药和抗精神病药血清浓度的影响：一项回顾性队列研究》的回应
Int J Clin Pharm. 2023 Oct;45(5):1307-1308. doi: 10.1007/s11096-023-01613-w. Epub 2023 Jun 15.
2
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study.CYP2D6 药物遗传学表型和表型转化对抗抑郁药和抗精神病药血清浓度的影响：一项回顾性队列研究。
Int J Clin Pharm. 2023 Oct;45(5):1107-1117. doi: 10.1007/s11096-023-01588-8. Epub 2023 May 11.
3
The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.细胞色素P450-2D6基因型对日常精神科实践中接受抗抑郁药和抗精神病药治疗的长期住院患者治疗药物监测的应用及解读的影响。
Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):107-14. doi: 10.1002/pds.1173.
4
Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics.等位基因变异对抗抑郁药和抗精神病药反应表型的贡献。
Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258 Suppl 1:12-20. doi: 10.1007/s00406-007-1004-z.
5
The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.传统治疗药物监测与药物遗传学检测在个性化医疗中的融合：聚焦于抗抑郁药。
Clin Pharmacol Ther. 2007 Jun;81(6):899-902. doi: 10.1038/sj.clpt.6100188. Epub 2007 Mar 28.
6
Is pharmacogenetic CYP2D6 testing useful?药物遗传学CYP2D6检测有用吗？
Tidsskr Nor Laegeforen. 2010 Nov 18;130(22):2224-8. doi: 10.4045/tidsskr.09.1445.
7
CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.CYP2D6 表型影响心境障碍儿科患者对阿立哌唑的耐受性。
J Child Adolesc Psychopharmacol. 2021 Feb;31(1):56-62. doi: 10.1089/cap.2020.0058. Epub 2020 Aug 25.
8
The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.AmpliChip CYP450基因分型检测：整合一种新的临床工具。
Mol Diagn Ther. 2006;10(3):135-51. doi: 10.1007/BF03256453.
9
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics.CYP2D6 和 CYP2C19 基因变异对服用抗抑郁药和抗精神病药的人群糖尿病风险的影响。
Genes (Basel). 2021 Nov 3;12(11):1758. doi: 10.3390/genes12111758.
10
Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.药物遗传学方法作为抗抑郁药和抗精神病药治疗监测的补充
Ther Drug Monit. 2000 Feb;22(1):114-7. doi: 10.1097/00007691-200002000-00024.

本文引用的文献

1
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study.CYP2D6 药物遗传学表型和表型转化对抗抑郁药和抗精神病药血清浓度的影响：一项回顾性队列研究。
Int J Clin Pharm. 2023 Oct;45(5):1107-1117. doi: 10.1007/s11096-023-01588-8. Epub 2023 May 11.
2
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.荷兰药物基因组学工作组（DPWG）关于CYP2D6、CYP3A4和CYP1A2与抗精神病药物之间基因-药物相互作用的指南。
Eur J Hum Genet. 2024 Mar;32(3):278-285. doi: 10.1038/s41431-023-01347-3. Epub 2023 Mar 31.
3
Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying *4 Variants: A Case Report.
两例携带*4 变异体的喹硫平严重药物不良反应患者：病例报告。
Int J Mol Sci. 2021 Jun 17;22(12):6480. doi: 10.3390/ijms22126480.
4
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.CYP2C19 和 CYP2D6 弱代谢和中间代谢状态与抗抑郁药和抗精神病药暴露的关联：系统评价和荟萃分析。
JAMA Psychiatry. 2021 Mar 1;78(3):270-280. doi: 10.1001/jamapsychiatry.2020.3643.
5
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.神经精神药理学治疗药物监测共识指南：2017 年更新版。
Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14.
6
Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.体外研究喹硫平的活性代谢物 N-去烷基喹硫平的代谢。
Drug Metab Dispos. 2012 Sep;40(9):1778-84. doi: 10.1124/dmd.112.045237. Epub 2012 Jun 11.